Sort
130,381 grants matching “hiv”
Effects of HIV, Cocaine, and Prolonged ART Use on Subclinical Cardiovascular Disease
$1,374,319Shenghan Lai · University Of Maryland Baltimore · U01 · FY2023 · DA
Long Acting Acceptable Microbicides: Novel Delivery, Activity and Pharmacodynamic
$1,374,317Robert Walter Buckheit · Imquest Biosciences · U19 · FY2008 · AI
GHESKIO HIV Clinical Trial Unit
$1,374,213Jean William Pape · Gheskio Center · UM1 · FY2013 · AI
Innate Discovery Team
$1,374,011Nina Bhardwaj · Duke University · U19 · FY2008 · AI
Global Network Data Coordinating Center
$1,373,972Elizabeth McClure · Research Triangle Institute · U01 · FY2010 · HD
Acute Hepatitis C Infection in Young Injectors
$1,373,874Kimberly Page · University Of New Mexico Health Scis Ctr · R01 · FY2016 · DA
HIV-1 Integrase
$1,373,844Stephen H Hughes · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
NextGen Long-acting and targeted combination ART for Children with HIV
$1,373,809Rodney J.y. Ho · University Of Washington · R33 · FY2025 · AI
Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies
$1,373,768Robert Yarchoan · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Infections, immunity, and inflammation in cancer
$1,373,590Eric A Engels · Division Of Cancer Epidemiology And Genetics · ZIA · FY2014 · CA
AIDS INTERNATIONAL TRAINING AND RESEARCH PROGRAM
$1,373,548Weill Medical College Of Cornell Univ · D43 · FY2001 · TW
Boston Alcohol Research Collaboration on HIV/AIDS - Comorbidity Center (Boston ARCH CC)
$1,373,231Michael D Stein · Boston University Medical Campus · P01 · FY2024 · AA
Research Resource for Human Organs and Tissues
$1,373,136John T Lonsdale · National Disease Research Interchange · U42 · FY2013 · OD
SAN FRANCISCO HIV VACCINE CLINICAL TRAILS UNIT
$1,373,041Public Health Foundation Enterprises · U01 · FY2003 · AI
Structure-Function Studies of the HIV-1 Envelope Glycoproteins and Development of VLP-forming vaccine strategies for HIV-1
$1,373,021Paolo Lusso · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
HEALTH PROMOTION AND DISEASE PREVENTION RESEARCH CENTERS - CENTER CATEGORY 1
$1,373,000Susan Tortolero · University Of Texas Hlth Sci Ctr Houston · U48 · FY2011 · DP
Examining Modifiable Psychosocial Predictors of HIV Seroconversion in a Large Nationwide Cohort of High Risk Men
$1,372,892H. Jonathon Rendina · Hunter College · UH3 · FY2019 · AI
Optimization of HIV vaccines for the induction of cross-reactive antibodies
$1,372,884Shan Lu · Univ Of Massachusetts Med Sch Worcester · U19 · FY2012 · AI
Investigating Transcriptional Responses to the Environment
$1,372,812Karen L Adelman · Environmental Health Sciences · Z01 · FY2007 · ES
Age-17 Follow-up of Home Visiting Intervention
$1,372,527David L Olds · University Of Rochester · R01 · FY2012 · DA
Transdiagnostic Intervention to Reduce Internalized Health-Related Stigma
$1,372,500Rebecca L Pearl · University Of Florida · DP2 · FY2022 · MH
Effects of HIV, Cocaine, and Prolonged ART Use on Subclinical Cardiovascular Disease
$1,371,707Shenghan Lai · Johns Hopkins University · U01 · FY2016 · DA
HAART to Prevent HIV Transmission to Infants In Botswana
$1,371,298Roger L Shapiro · Harvard School Of Public Health · U01 · FY2008 · AI
Cornell Clinical Trials Unit
$1,371,244Roy M Gulick · Weill Medical Coll Of Cornell Univ · U01 · FY2010 · AI
HIVRAD: Structural approaches to vaccine development
$1,371,237Dana-Farber Cancer Institute · P01 · FY2004 · AI